Factors associated to prevalence and incidence of carbapenem-resistant enterobacteriaceae fecal carriage: A cohort study in a Mexican tertiary care hospital

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Torres Gonzalez, Pedro ^a   Cervera Hernandez, Miguel Enrique ^a   Niembro Ortega, María Dolores ^a   Leal Vega, Francisco ^a   Cruz Hervert, Luis Pablo ^b   García García, Lourdes ^b   Galindo Fraga, Arturo ^a   Martinez Gamboa, Areli ^a   Bobadilla Del Valle, Miriam ^a   Sifuentes Osornio, Jose ^a   Ponce De Leon, Alfredo ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; ERTAPENEM; IMIPENEM; MEROPENEM; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; COHORT ANALYSIS; FECES ANALYSIS; FECES CULTURE; FEMALE; HEALTH CARE FACILITY; HEALTH PROGRAM; HEMATOLOGIC MALIGNANCY; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE UNIT; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NONHUMAN; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SEPSIS; TERTIARY CARE CENTER; CROSS INFECTION; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FECES; HETEROZYGOTE; HOSPITALIZATION; MICROBIOLOGY; MIDDLE AGED; PROCEDURES; TERTIARY HEALTH CARE;

ADULT; ANTI-BACTERIAL AGENTS; CARBAPENEMS; CARRIER STATE; COHORT STUDIES; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FECES; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; TERTIARY HEALTHCARE;

EID: 84947238288     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139883     Document Type: Article

References (26)

1. Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends in molecular medicine. 2012; 18(5):263-72. Epub 2012/04/07. doi: 10.1016/j.molmed.2012.03. 003 PMID: 22480775.
2. Solomon SL, Oliver KB. Antibiotic resistance threats in the United States: stepping back from the brink. American family physician. 2014; 89(12):938-41. Epub 2014/08/28. PMID: 25162160.
3. Swaminathan M, Sharma S, Poliansky Blash S, Patel G, Banach DB, Phillips M, et al. Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America. 2013; 34(8):809-17. Epub 2013/07/11. doi: 10.1086/671270 PMID: 23838221.
4. Akova M, Daikos GL, Tzouvelekis L, Carmeli Y. Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2012; 18(5):439-48. Epub 2012/04/18. doi: 10.1111/j.1469-0691.2012.03823.x PMID: 22507111.
5. Wiener-Well Y, Rudensky B, Yinnon AM, Kopuit P, Schlesinger Y, Broide E, et al. Carriage rate of carbapenem-resistant Klebsiella pneumoniae in hospitalised patients during a national outbreak. The Journal of hospital infection. 2010; 74(4):344-9. Epub 2009/09/29. doi: 10.1016/j.jhin.2009.07.022 PMID: 19783067.
6. Ben-David D, Masarwa S, Navon-Venezia S, Mishali H, Fridental I, Rubinovitch B, et al. Carbapenemresistant Klebsiella pneumoniae in post-acute-care facilities in Israel. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America. 2011; 32(9):845-53. Epub 2011/08/11. doi: 10.1086/661279 PMID: 21828964.
7. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrobial agents and chemotherapy. 2008; 52(3):1028-33. Epub 2007/12/19. doi: 10. 1128/AAC.01020-07 PMID: 18086836; PubMed Central PMCID: PMC2258527.
8. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of chronic diseases. 1987; 40(5):373-83. Epub 1987/01/01. PMID: 3558716.
9. Rice LB. Progress and challenges in implementing the research on ESKAPE pathogens. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America. 2010; 31 Suppl 1:S7-10. Epub 2010/10/12. doi: 10.1086/655995 PMID: 20929376.
10. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2012; 18(3):268-81. Epub 2011/07/29. doi: 10.1111/j.1469-0691.2011.03570.x PMID: 21793988.
11. Landman D, Salvani JK, Bratu S, Quale J. Evaluation of techniques for detection of carbapenem-resistant Klebsiella pneumoniae in stool surveillance cultures. Journal of clinical microbiology. 2005; 43 (11):5639-41. Epub 2005/11/08. doi: 10.1128/JCM.43.11.5639-5641.2005 PMID: 16272497; PubMed Central PMCID: PMC1287836.
12. Performance Standards for Antimicrobial Susceptibility Testing Twenty-third Information Supplement. CLSI document M100-S23. CLSI document M100-S23. CLSI, Wayne, PA, USA, 2013.
13. Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clinical microbiology reviews. 2007; 20(3):440-58, table of contents. Epub 2007/07/17. doi: 10.1128/CMR.00001-07 PMID: 17630334; PubMed Central PMCID: PMC1932750.
14. Nordmann P, Poirel L, Carrer A, Toleman MA, Walsh TR. How to detect NDM-1 producers. Journal of clinical microbiology. 2011; 49(2):718-21. Epub 2010/12/03. doi: 10.1128/JCM.01773-10 PMID: 21123531; PubMed Central PMCID: PMC3043507.
15. Pantel A, Marchandin H, Prere MF, Boutet-Dubois A, Brieu-Roche N, Gaschet A, et al. Faecal carriage of carbapenemase-producing Gram-negative bacilli in hospital settings in southern France. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology. 2014. Epub 2014/12/24. doi: 10.1007/s10096-014-2298-1 PMID: 25532506.
16. Zhao ZC, Xu XH, Liu MB, Wu J, Lin J, Li B. Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university hospital. American journal of infection control. 2014; 42(5):e61-4. Epub 2014/04/30. doi: 10.1016/j.ajic.2014.01.024 PMID: 24773806.
17. Borer A, Saidel-Odes L, Eskira S, Nativ R, Riesenberg K, Livshiz-Riven I, et al. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae. American journal of infection control. 2012; 40 (5):421-5. Epub 2011/09/13. doi: 10.1016/j.ajic.2011.05.022 PMID: 21906844.
18. Wingard JR, Dick J, Charache P, Saral R. Antibiotic-resistant bacteria in surveillance stool cultures of patients with prolonged neutropenia. Antimicrobial agents and chemotherapy. 1986; 30(3):435-9. Epub 1986/09/01. PMID: 3640591; PubMed Central PMCID: PMC180575.
19. Husni R, Hachem R, Hanna H, Raad I. Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America. 2002; 23(2):102-3. Epub 2002/03/15. doi: 10.1086/502016 PMID: 11893144.
20. Schwaber MJ, Lev B, Israeli A, Solter E, Smollan G, Rubinovitch B, et al. Containment of a countrywide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2011; 52(7):848-55. Epub 2011/02/15. doi: 10.1093/cid/cir025 PMID: 21317398.
21. Bonten MJ, Slaughter S, Ambergen AW, Hayden MK, van Voorhis J, Nathan C, et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Archives of internal medicine. 1998; 158(10):1127-32. Epub 1998/05/30. PMID: 9605785.
22. Papadimitriou-Olivgeris M, Marangos M, Fligou F, Christofidou M, Bartzavali C, Anastassiou ED, et al. Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission. The Journal of antimicrobial chemotherapy. 2012; 67(12):2976-81. Epub 2012/08/29. doi: 10.1093/jac/dks316 PMID: 22927316.
23. Rodriguez-Osorio CA, Sanchez-Martinez CO, Araujo-Melendez J, Criollo E, Macias-Hernandez AE, Ponce-de-Leon A, et al. Impact of ertapenem on antimicrobial resistance in a sentinel group of Gramnegative bacilli: a 6 year antimicrobial resistance surveillance study. The Journal of antimicrobial chemotherapy. 2014. Epub 2014/12/07. doi: 10.1093/jac/dku471 PMID: 25480492.
24. Panda S, El khader I, Casellas F, Lopez Vivancos J, Garcia Cors M, Santiago A, et al. Short-term effect of antibiotics on human gut microbiota. PloS one. 2014; 9(4):e95476. Epub 2014/04/22. doi: 10.1371/journal.pone.0095476 PMID: 24748167; PubMed Central PMCID: PMC3991704.
25. Saidel-Odes L, Borer A. Limiting and controlling carbapenem-resistant Klebsiella pneumoniae. Infection and drug resistance. 2013; 7:9-14. Epub 2013/12/20. doi: 10.2147/IDR.S44358 PMID: 24353433; PubMed Central PMCID: PMC3862651.
26. Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. The Journal of antimicrobial chemotherapy. 2005; 56(1):52-9. Epub 2005/05/27. doi: 10.1093/jac/dki166 PMID: 15917288.